Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1560 of 6351
-
New drug cocktail aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis study is a prospective, exploratory clinical study design, and plans to enroll 33 patients with HR+HER2 low expression breast cancer who received pyrotinib combined with darcili and standard endocrine neoadjuvant therapy to evaluate the efficacy of this regimen in HR+HER2 lo…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists hunt for genetic clues to deadly heart side effect of cancer drugs
Knowledge-focused Recruiting nowImmune checkpoint inhibitors (ICI) are active in multiple cancers. Their main drawback is the incidence of immune related adverse events; among which ICI-myocarditis (ICIM) is rare but can be the most life-threatening (up to 50% lethal). ICIM is due to ICI unleashing cytotoxic au…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New app could spot jaundice in newborns with a simple eye photo
Diagnosis Recruiting nowAbout 60% of babies born after 36 weeks of pregnancy have jaundice during the first two weeks of life. Due to the accumulation of bilirubin in the bloodstream, jaundiced babies appear yellow, which allows healthcare professionals to visually identify significantly jaundiced babie…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New hope for toddlers with aggressive brain cancer: experimental spinal-fluid chemo
Disease control Recruiting nowPilot study to determine feasibility of adding intrathecal chemotherapy and maintenance therapy after high dose chemotherapy for treatment of newly diagnosed HR-EBTs in patients less than 6 years of age.
Early phase 1 • Sponsor: C17 Council • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Eye implant aims to restore sight in advanced AMD patients
Disease control Recruiting nowThis study aims to expand the CE mark IFU of the SING IMT™ to pseudophakic (patients with an intraocular lents) patients with late stage of AMD (Age-Related Macular Degeneration) and bilateral central vision impairment. This randomized, international, multicenter study will evalu…
Sponsor: VisionCare, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Cell injection aims to repair damaged livers in early trial
Disease control By invitation onlyThree sequential dose cohorts are predefined for single administration: Cohort 1 (1.0 × 10⁶ cells/kg), Cohort 2 (2.0 × 10⁶ cells/kg), and Cohort 3 (4.0 × 10⁶ cells/kg). Escalation proceeds from Cohort 1 to Cohort 3 according to a "3 + 3" algorithm, with each subject receiving a s…
Phase 1/2 • Sponsor: Shanghai Huicun Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill could help control blood disorder when standard drugs fail
Disease control Recruiting nowThis trial adopts an open, randomized, parallel controlled, multicenter clinical trial design planning to enroll patients with polycythemia vera who are resistant/intolerant to hydroxyurea or interferon. The study divided into two stages: dose exploration stage: three dose groups…
Phase 2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New eye drug trial aims to save sight in Hard-to-Treat AMD
Disease control Not yet recruitingType 3 macular neovascularization (MNV) is a subtype of neovascular age-related macular degeneration accounting for 10-20% of cases, notable for high rates of bilateral involvement and risk of profound vision loss, particularly if undertreated. Early and proactive therapy is cruc…
Phase 4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New cocktail of cancer drugs shows promise for tough brain tumors
Disease control Recruiting nowClinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX intolerance) or Temozolomide (TMZ) Combined with Orelabrutinib and Selinexor in the Treatment of Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma This study adopts an ope…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New PET scan may solve brain tumor puzzle: regrowth or side effect?
Diagnosis CompletedThis study is designed to prospectively analyze \[18F\]FET PET image data obtained retrospectively in the routine clinical care of glioma patients. The study will analyse the data from participants with grade (1-4) glioma after primary treatment according to local clinical practi…
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Engineered virus takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis is a clinical study for patients with advanced solid tumors who have limited or no effective treatment options available. The study aims to evaluate a new investigational drug called VSV-02 Injection, which is developed by Shanghai Rongrui Pharmaceutical Technology Co., Ltd.…
Phase 1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can magnetic pulses to the brain ease OCD? new trial investigates
Disease control Recruiting nowThe purpose of this study is to investigate the differences in therapeutic efficacy of different deep Transcranial Magnetic Stimulation (deep TMS) treatment coils and different brain stimulation targets on obsessive-compulsive symptoms, and to explore the neural mechanisms of obs…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Avatar game teaches heart attack patients how to recover
Disease control CompletedThis study looks at whether a tablet-based education game helps people recover better after a heart attack. When people leave the hospital after a heart attack, they are usually given advice about their medicines, follow-up visits, cardiac rehabilitation, and warning signs to wat…
Sponsor: Suleyman Demirel University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New microscope could speed up cervical cancer diagnosis in minutes
Diagnosis Recruiting nowAll patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
New shortcut for blood pressure treatment?
Disease control Recruiting nowThe purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural appr…
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Sponge and suction could stop deadly leaks after colon surgery
Prevention Recruiting nowEvaluate the safety and efficacy of postoperative Pre-emptive EVT (PEVT) in reducing the incidence of anastomotic leaks within 30 days after surgery in patients with colorectal cancer. Compare the differences between the PEVT group and the control group in terms of operation time…
Sponsor: Nanchong Central Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could a direct brain artery injection improve stroke recovery?
Disease control By invitation onlyThe purpose of this study is to determine the safety and feasibility of using intra-arterial Tenecteplase in patients undergoing blood clot extraction for treatment of acute ischemic (non-bleeding) stroke. Intravenous Tenecteplase is FDA-approved to treat patients with an ischemi…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug YL242 takes on advanced solid tumors in first human trial
Disease control Recruiting nowThis is a multicenter, open-label study to evaluate the safety and tolerability of YL242 monotherapy and combination in participants with advanced solid malignant tumors.
Phase 1/2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New study aims to help hispanic autistic toddlers with culturally sensitive therapy
Symptom relief Recruiting nowPurpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure" used in a Culturally and Linguistically Responsive adaptation of Pathways Early Intervention (CLR-Pathways) is the key to improving social communication, languag…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New study tests safer, faster fertility option for PCOS patients
Disease control Recruiting nowAssisted Reproductive Technologies (ART) aim to increase success rates while minimizing patient risks. For women with high AFC or PCOS, conventional IVF carries a high risk of OHSS (Ho et al., 2019). A modern IVF strategy to prevent this uses a GnRH agonist trigger, requiring a "…
Sponsor: Mỹ Đức Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC